abstract |
Compounds having the formula (I) are described: wherein R1, R2 and R3 are as defined herein and methods for producing and using them, including their use as inhibitors of BMP1, TLL1 and / or TLL2 and in the treatment of diseases associated with the activity of BMP1, TLL1 and / or TLL2. (See Formula). |